Duke Debates Hematology 2025 DCN
This annual event brings together experts in the field of Hematologic Malignancies to discuss advances in treatment and to debate current treatment paradigms. The aim is to educate oncologists, hematologists, and the healthcare team regarding evolving and contemporary standards of care for the optimal treatments of patients with hematologic malignancies. New opportunities include Meet the Expert engagements to connect attendees with nationally recognized experts and Clinical Quandary Panels will discuss and debate challenging case scenarios submitted by attendees. In addition, an Advanced practitioner mini session is offered.
Target Audience
Medical Students
Nurse Practitioners
Physicians
Physician Assistants
Pharmacists
Learning Objectives
Describing emerging data and recent advances in the management of hematologic malignancies.
Examining the use of recent advances in treatment through lectures, case-based debates.
Comparing traditional and emerging treatment options in the management of hematologic disease.
Debating treatment options and management strategies.
Evaluating the role CAR T, transplant and bi specifics in hematologic malignancies.
linda sutton
TRacy Torgerson NP
Catherine Gaines PA
Sally Barbour pharmacist
Pamela Scarborough pharm tech
Harry Erba
Therese Hennig
Mitchel Horwitz
Cristiana Chase
Danielle Brander
Yubin Kang
Lindsey Rein
JJ Strouse
Speaker
Tae Choi
Luciano Costa
Sascha Tuchman
Peter Voorhees
Carlos DeCastro
Andrea Sitlinger
Jonathan Friedberg
Jonathan Cohen
Debbie Stephens
Jie Wang
Matt Lunning
Adetoa Kassim
Ann Eisfeld
ABIM MOC
ACPE - Pharmacy Technician
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
IACET CEU
JA Credit - AH
Available Credit
- 14.75 ABIM MOC
- 14.75 ACPE - Pharmacist
- 14.75 ACPE - Pharmacy Technician
- 14.75 AMA PRA Category 1 Credit(s)™
- 14.75 ANCC
- 14.75 Attendance
- 1.47 IACET CEU
- 14.75 JA Credit - AH
- 14.75 Approved for AMA PRA Category 1 Credit(s)™